Literature DB >> 31965347

Fabrications of boron-containing apatite ceramics via ultrasonic spray-pyrolysis route and their responses to immunocytes.

Daiki Nakagawa1, Mariko Nakamura1, Shigenori Nagai2, Mamoru Aizawa3.   

Abstract

Immunotherapy without side effects has been expected as a novel medical treatment for cancer. However, drugs such as cytokines typically used for immunotherapy are very expensive. Therefore, we propose the concept of immunoceramics that affect the immune system. Previous studies have shown that polymers including the phenylboronic acid group activate lymphocytes. This activation may be due to interaction between the sugar chains in cells and the OH group in B(OH)3 formed via dissociation of the BO2 group. In the present study, boron-containing apatite (BAp; Ca9.5+0.5x{(PO4)6-x(BO3)x}{(BO2)1-xOx} (0 ≤ x ≤ 1)) was successfully fabricated via the ultrasonic spray-pyrolysis (USSP) route. We examined the material properties of the BAp ceramics with an aim to application as immunoceramics and the responses of immune cells to the BAp ceramics. The crystalline phases of the BAp ceramics included the apatite phase and infrared (IR) absorption of BO2 and BO3 groups was detected in the BAp ceramics. The cellular response of immune cells derived from mice spleens to dense BAp ceramics was examined next. The proportion of helper T cells and killer T cells on BAp (x = 0.4) ceramics increased compared to that on hydroxyapatite (Ca10(PO4)6(OH)2; HAp) ceramics and on a control. These results indicate that BAp (x = 0.4) ceramics fabricated via the USSP route can be expected to act as immunoceramics that can affect the immune system.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31965347     DOI: 10.1007/s10856-020-6358-z

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  12 in total

1.  Paper chromatography of carbohydrates and related compounds in the presence of benzeneboronic acid.

Authors:  E J BOURNE; E M LEES; H WEIGEL
Journal:  J Chromatogr       Date:  1963-06

2.  Sustained release of anti-PD-1 peptide for perdurable immunotherapy together with photothermal ablation against primary and distant tumors.

Authors:  Lihua Luo; Jie Yang; Chunqi Zhu; Mengshi Jiang; Xiaomeng Guo; Wei Li; Xiaoyi Yin; Hang Yin; Bin Qin; Xiaoling Yuan; Qingpo Li; Yongzhong Du; Jian You
Journal:  J Control Release       Date:  2018-04-04       Impact factor: 9.776

3.  Human regulatory T cells rapidly suppress T cell receptor-induced Ca(2+), NF-κB, and NFAT signaling in conventional T cells.

Authors:  Angelika Schmidt; Nina Oberle; Eva-Maria Weiss; Diana Vobis; Stefan Frischbutter; Ria Baumgrass; Christine S Falk; Mathias Haag; Britta Brügger; Hongying Lin; Georg W Mayr; Peter Reichardt; Matthias Gunzer; Elisabeth Suri-Payer; Peter H Krammer
Journal:  Sci Signal       Date:  2011-12-20       Impact factor: 8.192

4.  Lectins: cell-agglutinating and sugar-specific proteins.

Authors:  N Sharon; H Lis
Journal:  Science       Date:  1972-09-15       Impact factor: 47.728

5.  Targeted delivery of oligonucleotides into tumor-associated macrophages for cancer immunotherapy.

Authors:  Zhen Huang; Zhengping Zhang; Yucui Jiang; Dachuan Zhang; Jiangning Chen; Lei Dong; Junfeng Zhang
Journal:  J Control Release       Date:  2011-11-18       Impact factor: 9.776

6.  Fabrications of boron-containing apatite ceramics via ultrasonic spray-pyrolysis route and their responses to immunocytes.

Authors:  Daiki Nakagawa; Mariko Nakamura; Shigenori Nagai; Mamoru Aizawa
Journal:  J Mater Sci Mater Med       Date:  2020-01-21       Impact factor: 3.896

7.  A role of valency of concanavalin A and its chemically modified derivatives in lymphocyte activation. Monovalent monomeric concanavalin A derivative can stimulate lymphocyte blastoid transformation.

Authors:  M Saito; F Takaku; M Hayashi; I Tanaka; Y Abe; Y Nagai; S Ishii
Journal:  J Biol Chem       Date:  1983-06-25       Impact factor: 5.157

Review 8.  'Borono-lectin' based engineering as a versatile platform for biomedical applications.

Authors:  Akira Matsumoto; Yuji Miyahara
Journal:  Sci Technol Adv Mater       Date:  2017-12-19       Impact factor: 8.090

9.  Suppression of immune regulatory cells with combined therapy of celecoxib and sunitinib in renal cell carcinoma.

Authors:  Qi Zhao; Jianming Guo; Guomin Wang; Yiwei Chu; Xiaoyi Hu
Journal:  Oncotarget       Date:  2017-01-03

10.  Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study.

Authors:  Christina Fitzmaurice; Tomi F Akinyemiju; Faris Hasan Al Lami; Tahiya Alam; Reza Alizadeh-Navaei; Christine Allen; Ubai Alsharif; Nelson Alvis-Guzman; Erfan Amini; Benjamin O Anderson; Olatunde Aremu; Al Artaman; Solomon Weldegebreal Asgedom; Reza Assadi; Tesfay Mehari Atey; Leticia Avila-Burgos; Ashish Awasthi; Huda Omer Ba Saleem; Aleksandra Barac; James R Bennett; Isabela M Bensenor; Nickhill Bhakta; Hermann Brenner; Lucero Cahuana-Hurtado; Carlos A Castañeda-Orjuela; Ferrán Catalá-López; Jee-Young Jasmine Choi; Devasahayam Jesudas Christopher; Sheng-Chia Chung; Maria Paula Curado; Lalit Dandona; Rakhi Dandona; José das Neves; Subhojit Dey; Samath D Dharmaratne; David Teye Doku; Tim R Driscoll; Manisha Dubey; Hedyeh Ebrahimi; Dumessa Edessa; Ziad El-Khatib; Aman Yesuf Endries; Florian Fischer; Lisa M Force; Kyle J Foreman; Solomon Weldemariam Gebrehiwot; Sameer Vali Gopalani; Giuseppe Grosso; Rahul Gupta; Bishal Gyawali; Randah Ribhi Hamadeh; Samer Hamidi; James Harvey; Hamid Yimam Hassen; Roderick J Hay; Simon I Hay; Behzad Heibati; Molla Kahssay Hiluf; Nobuyuki Horita; H Dean Hosgood; Olayinka S Ilesanmi; Kaire Innos; Farhad Islami; Mihajlo B Jakovljevic; Sarah Charlotte Johnson; Jost B Jonas; Amir Kasaeian; Tesfaye Dessale Kassa; Yousef Saleh Khader; Ejaz Ahmad Khan; Gulfaraz Khan; Young-Ho Khang; Mohammad Hossein Khosravi; Jagdish Khubchandani; Jacek A Kopec; G Anil Kumar; Michael Kutz; Deepesh Pravinkumar Lad; Alessandra Lafranconi; Qing Lan; Yirga Legesse; James Leigh; Shai Linn; Raimundas Lunevicius; Azeem Majeed; Reza Malekzadeh; Deborah Carvalho Malta; Lorenzo G Mantovani; Brian J McMahon; Toni Meier; Yohannes Adama Melaku; Mulugeta Melku; Peter Memiah; Walter Mendoza; Tuomo J Meretoja; Haftay Berhane Mezgebe; Ted R Miller; Shafiu Mohammed; Ali H Mokdad; Mahmood Moosazadeh; Paula Moraga; Seyyed Meysam Mousavi; Vinay Nangia; Cuong Tat Nguyen; Vuong Minh Nong; Felix Akpojene Ogbo; Andrew Toyin Olagunju; Mahesh Pa; Eun-Kee Park; Tejas Patel; David M Pereira; Farhad Pishgar; Maarten J Postma; Farshad Pourmalek; Mostafa Qorbani; Anwar Rafay; Salman Rawaf; David Laith Rawaf; Gholamreza Roshandel; Saeid Safiri; Hamideh Salimzadeh; Juan Ramon Sanabria; Milena M Santric Milicevic; Benn Sartorius; Maheswar Satpathy; Sadaf G Sepanlou; Katya Anne Shackelford; Masood Ali Shaikh; Mahdi Sharif-Alhoseini; Jun She; Min-Jeong Shin; Ivy Shiue; Mark G Shrime; Abiy Hiruye Sinke; Mekonnen Sisay; Amber Sligar; Muawiyyah Babale Sufiyan; Bryan L Sykes; Rafael Tabarés-Seisdedos; Gizachew Assefa Tessema; Roman Topor-Madry; Tung Thanh Tran; Bach Xuan Tran; Kingsley Nnanna Ukwaja; Vasiliy Victorovich Vlassov; Stein Emil Vollset; Elisabete Weiderpass; Hywel C Williams; Nigus Bililign Yimer; Naohiro Yonemoto; Mustafa Z Younis; Christopher J L Murray; Mohsen Naghavi
Journal:  JAMA Oncol       Date:  2018-11-01       Impact factor: 31.777

View more
  2 in total

1.  Fabrications of boron-containing apatite ceramics via ultrasonic spray-pyrolysis route and their responses to immunocytes.

Authors:  Daiki Nakagawa; Mariko Nakamura; Shigenori Nagai; Mamoru Aizawa
Journal:  J Mater Sci Mater Med       Date:  2020-01-21       Impact factor: 3.896

Review 2.  Sonoproduction of nanobiomaterials - A critical review.

Authors:  Sze Shin Low; Maxine Yew; Chang Nong Lim; Wai Siong Chai; Liang Ee Low; Sivakumar Manickam; Beng Ti Tey; Pau Loke Show
Journal:  Ultrason Sonochem       Date:  2021-12-22       Impact factor: 7.491

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.